Downstream of the neddylation pathway, the NF-κB signaling pathway in cancer cells also contributes to the chemotherapy resistance of cancer cells [48], because it widely drives the transcription of multiple anti-apoptotic proteins and proinflammatory factors [74]. The gene discussed is NFKB1; the disease is cancer.